FDA Approves EVARREST™ Fibrin Sealant Patch

Ethicon Biosurgery, has announced that the U.S. Food and Drug Administration (FDA) has approved EVARREST™ Fibrin Sealant Patch, a novel product that it says rapidly and reliably aids in stopping problematic bleeding during surgery.



FDA Approves EVARREST™ Fibrin Sealant Patch (via PR Newswire)

SOMERVILLE, N.J., Dec. 7, 2012 /PRNewswire/ — Ethicon Biosurgery, Division of Ethicon, Inc., a worldwide leader in hemostasis and sealing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved EVARREST™ Fibrin Sealant Patch, a novel product that rapidly and reliably…


published: December 10, 2012 in: Approval/Clearance, Ethicon, Specialty

Most read

Latest

^